Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During Pregnancy

Mette Julsgaard*, Jantien W. Wieringa, Simon M.D. Baunwall, Bo M. Bibby, Gertjan J.A. Driessen, Linda Kievit, Jacob B. Brodersen, Anja Poulsen, Jens Kjeldsen, Mette M. Hansen, Hai Q. Tang, Christina L. Balmer, Henning Glerup, Jakob B. Seidelin, Kent V. Haderslev, Lise Svenningsen, Signe Wildt, Mie A. Juel, Anders Neumann, Jens FuglsangTine Jess, Anne Mette Haase, Christian L. Hvas, Jens Kelsen, C. Janneke van der Woude, NEXUS Collaborator Group, Uffe Lund Lystbæk

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
5 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During Pregnancy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science